Schrodinger (NASDAQ:SDGR) Rating Lowered to Sell at Wall Street Zen

Schrodinger (NASDAQ:SDGR) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Saturday.

A number of other brokerages have also commented on SDGR. KeyCorp decreased their target price on Schrodinger from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Thursday. The Goldman Sachs Group assumed coverage on Schrodinger in a report on Monday, September 29th. They set a “neutral” rating and a $19.00 price objective for the company. Bank of America raised Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 target price on the stock in a research report on Monday, December 15th. Weiss Ratings reissued a “sell (e+)” rating on shares of Schrodinger in a research report on Tuesday, October 14th. Finally, TD Cowen lowered their price objective on shares of Schrodinger from $33.00 to $24.00 and set a “buy” rating on the stock in a report on Thursday. Six equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $24.33.

Schrodinger Stock Down 1.2%

NASDAQ:SDGR opened at $18.39 on Friday. Schrodinger has a twelve month low of $15.99 and a twelve month high of $28.47. The company has a fifty day moving average of $17.98 and a 200-day moving average of $19.49. The firm has a market capitalization of $1.35 billion, a P/E ratio of -7.63 and a beta of 1.54.

Schrodinger (NASDAQ:SDGR) last posted its quarterly earnings results on Wednesday, November 5th. The company reported ($0.45) EPS for the quarter, topping analysts’ consensus estimates of ($0.72) by $0.27. Schrodinger had a negative net margin of 68.49% and a negative return on equity of 48.24%. The business had revenue of $54.32 million during the quarter, compared to analysts’ expectations of $50.51 million. During the same period last year, the company posted ($0.87) earnings per share. The business’s quarterly revenue was up 53.9% on a year-over-year basis. On average, analysts anticipate that Schrodinger will post -2.37 EPS for the current fiscal year.

Insider Buying and Selling at Schrodinger

In related news, insider Margaret Dugan sold 1,395 shares of the business’s stock in a transaction dated Thursday, October 16th. The shares were sold at an average price of $21.07, for a total transaction of $29,392.65. Following the transaction, the insider directly owned 24,574 shares in the company, valued at approximately $517,774.18. The trade was a 5.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 21.00% of the stock is owned by insiders.

Hedge Funds Weigh In On Schrodinger

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Farther Finance Advisors LLC increased its position in shares of Schrodinger by 347.4% during the second quarter. Farther Finance Advisors LLC now owns 1,284 shares of the company’s stock valued at $26,000 after acquiring an additional 997 shares during the last quarter. Bayforest Capital Ltd bought a new position in Schrodinger in the 2nd quarter valued at $30,000. Aster Capital Management DIFC Ltd increased its position in shares of Schrodinger by 212.4% during the 3rd quarter. Aster Capital Management DIFC Ltd now owns 1,943 shares of the company’s stock valued at $39,000 after purchasing an additional 1,321 shares during the last quarter. State of Wyoming purchased a new stake in shares of Schrodinger during the 2nd quarter valued at $39,000. Finally, SBI Securities Co. Ltd. raised its stake in shares of Schrodinger by 110.4% during the 3rd quarter. SBI Securities Co. Ltd. now owns 2,127 shares of the company’s stock worth $43,000 after purchasing an additional 1,116 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Key Stories Impacting Schrodinger

Here are the key news stories impacting Schrodinger this week:

• Positive Sentiment: Schrödinger announced a partnership with Eli Lilly to integrate Lilly’s TuneLab AI drug‑discovery platform into Schrödinger’s LiveDesign enterprise informatics platform, making TuneLab a priority interface for participating biotech customers — this strengthens LiveDesign’s product value and could accelerate commercial deals or usage-based revenue. Business Wire
• Positive Sentiment: Media coverage highlights Lilly’s broader pact (including Revvity) to provide AI-driven drug‑discovery capabilities — public attention and third‑party ecosystem involvement can increase demand for Schrödinger’s software interfaces and partnerships. MSN
• Neutral Sentiment: TD Cowen reduced its price target from $33 to $24 but maintained a “buy” rating — this narrows analyst-implied upside while still signaling confidence in long‑term growth potential. TickerReport
• Neutral Sentiment: KeyCorp lowered its target from $28 to $25 and kept an “overweight” rating — another mixed signal: lower near‑term targets but continued positive stance on the business model. TickerReport
• Neutral Sentiment: Market commentary comparing Schrodinger with peers appears, but offers limited incremental near‑term impact; useful for relative valuation context. American Banking News
• Negative Sentiment: UBS initiated coverage with a “hold” and a $18 price target (below recent levels), which could exert downward pressure or limit buying interest until catalysts justify re‑rating. MSN

About Schrodinger

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.